Alembic Pharmaceuticals receives USFDA Final Approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg.
National, 30th September 2024: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug
Read More